I-Mab Biopharma
IMAB
#9149
Rank
$75.22 M
Marketcap
$0.92
Share price
-3.17%
Change (1 day)
-40.83%
Change (1 year)

I-Mab Biopharma (IMAB) - Total debt

Total debt on the balance sheet as of September 2024 : $3.78 Million USD

According to I-Mab Biopharma's latest financial reports the company's total debt is $3.78 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

I-Mab Biopharma - Total debt on balance sheet (from 2024 to 2023)

Total debt by year

Year Total debt Change
2022-12-31$10.87 M-38.39%
2021-12-31$17.64 M746.35%
2020-12-31$2.08 M-89.01%
2019-12-31$18.96 M-11.28%
2018-12-31$21.37 M-34.7%
2017-12-31$32.74 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.51 B 13,449.75%๐Ÿ‡บ๐Ÿ‡ธ USA